Jana Medical Company (TADAWUL:9616)

Jana Medical Company Cash Flow Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-23.17	5.41	5.22
Depreciation & Amortization	0.33	0.38	0.22
Other Amortization	0	0	0
Loss (Gain) From Sale of Assets	0	-	-
Provision & Write-off of Bad Debts	8.14	3.18	0.65
Other Operating Activities	10.41	0.19	0.77
Change in Accounts Receivable	14.77	-30.88	-32.31
Change in Inventory	-1.1	8.74	-7.89
Change in Accounts Payable	-0.66	0.07	-0.09
Change in Other Net Operating Assets	-3.41	0.28	-2.98
Operating Cash Flow	5.33	-12.62	-36.41
Capital Expenditures	-0.01	-0.16	-0.36
Sale of Property, Plant & Equipment	0	-	-
Sale (Purchase) of Intangibles	-0.03	-0.08	-0
Investing Cash Flow	-0.04	-0.24	-0.36
Short-Term Debt Issued	-	4.82	-
Long-Term Debt Issued	52	48.03	29.75
Total Debt Issued	52	52.85	29.75
Short-Term Debt Repaid	-4.88	-	-5.72
Long-Term Debt Repaid	-51.2	-44.88	-8.76
Total Debt Repaid	-56.09	-44.88	-14.47
Net Debt Issued (Repaid)	-4.08	7.97	15.28
Issuance of Common Stock	26.05	-	22.06
Other Financing Activities	-10.99	4.94	-
Financing Cash Flow	10.97	12.9	37.34
Net Cash Flow	16.26	0.05	0.57
Free Cash Flow	5.32	-12.78	-36.77
Free Cash Flow Margin	14.48%	-20.82%	-85.42%
Free Cash Flow Per Share	2.00	-4.97	-18.29
Cash Interest Paid	-	-	2.04
Levered Free Cash Flow	9.9	-8.58	-
Unlevered Free Cash Flow	14.74	-5.52	-
Change in Working Capital	9.6	-21.78	-43.27

Source: S&P Global Market Intelligence. Standard template. Financial Sources.